Christina Lake Cannabis Announces Filing of Q1 Financial Statements
26 Juni 2024 - 1:54AM
Christina Lake Cannabis Corp. ("CLC" or the
"Company") (CSE: CLC) is pleased to confirm that further to its
news releases dated April 3, 2024, April 17, 2024, May 1, 2024, May
15, 2024, May 29, 2024, June 3, 2024, and June 18, 2024 (the
"Releases"), the Company has filed on SEDAR its Q1 financial
statements, accompanying management discussion and analysis and
related CEO and CFO certifications for the period ended February
29, 2024 (the "Quarterly Filings"). The Quarterly Filings can be
obtained on the Company's SEDAR profile at www.sedarplus.ca.
The management cease trade order formerly
granted on April 3, 2024, by applicable securities regulatory
authorities, has been revoked and directors and officers of the
Company will be permitted to trade securities of the Company.
ABOUT CLC
Christina Lake Cannabis is a licensed producer
of cannabis under the Cannabis Act. It has secured a standard
cultivation license and corresponding processing amendment from
Health Canada (March 2020 and August 2020, respectively) as well as
a research and development license (early 2020). Christina Lake
Cannabis’ facility consists of a 32-acre property, which includes
over 950,000 square feet of outdoor grow space, offices,
propagation and drying rooms, research facilities, and a facility
dedicated to processing and extraction. Christina Lake Cannabis
also owns a 99-acre plot of land adjoining its principal site. CLC
focuses its production on creating high quality extracts and
distillate for its B2B client base with proprietary strains
specifically developed for outdoor cultivation to enhance
extraction quality.
For more information about CLC, please visit:
www.christinalakecannabis.com
Jennifer SmithInvestor Relations and Media
Inquiriesinvestors@clcannabis.com 902-229-7265
Forward Looking Information and Risk
Factors
This news release contains statements and
information that may constitute "forward-looking information"
within the meaning of applicable securities legislation, including
statements identified by the use of words such as "will",
"expects", "positions", "believe", "potential" and similar words,
including negatives thereof, or other similar expressions
concerning matters that are not historical facts.
Such forward-looking information is not
representative of historical facts or information or current
condition, but instead represent only the Company's beliefs
regarding future events, plans or objectives, many of which, by
their nature, are inherently uncertain and outside of the Company's
control. Generally, such forward-looking information can be
identified by the use of forward-looking terminology such as
"plans", "expects" or "does not expect", "is expected", "budget",
"scheduled", "estimates", "forecasts", "intends", "anticipates" or
"does not anticipate", or "believes", or variations of such words
and phrases or may contain statements that certain actions, events
or results "may", "could", "would", "might" or "will be taken",
"will continue", "will occur" or "will be achieved".
The forward-looking information contained in
this news release are made as of the date of this news release, and
the Company does not undertake to update any forward-looking
information and/or forward-looking statements that are contained or
referenced herein, except in accordance with applicable securities
laws. All subsequent written and oral forward-looking information
and statements attributable to the Company or persons acting on its
behalf are expressly qualified in their entirety by this
notice.
Core Laboratories (NYSE:CLB)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Core Laboratories (NYSE:CLB)
Historical Stock Chart
Von Jan 2024 bis Jan 2025